CONFIRMED SPEAKERS

Matthew Jackson

Matthew Jackson

Matt Jackson Patient 17 Imperial College London

Abstract

Matt was a patient on the 2019-2020 Psilocybin for major depression randomised control trial held in London. Guided by Michelle Baker Jones & Dr J Martell

Biography

Matt Jackson is a father of 3 boys & lives in a rural village in Kent (UK). After a series of life changing events he became severely depressed. Having tried psychotherapy & SSRI’s over a number of years with little improvement, I heard about the psilocybin trials in the USA from a friend there.


After reading around the subject of psilocybin and the treatment of depression. I considered the evidence and it seemed worth exploring. I wrote to Imperial College in August2018 & asked to be considered for their next trial. I was excepted onto the trial & underwent treatment at Imperial during the summer of 2019.


The results of two 25mg doses of psilocybin three weeks apart & phycological support have been transformative. To date, I have been depression free and my quality of life is greatly improved.

NEWSLETTER

STAY IN TOUCH

Be the first to learn about the ticket sale, speaker announcements and all things ICPR.